Article info

Download PDFPDF

Original research
Efficacy and biomarker analysis of nivolumab plus gemcitabine and cisplatin in patients with unresectable or metastatic biliary tract cancers: results from a phase II study

Authors

  1. Correspondence to Professor Weidong Han; hanwdrsw69{at}yahoo.com; Dr Qian Mei; meiqnn{at}hotmail.com
View Full Text

Citation

Feng K, Liu Y, Zhao Y, et al
Efficacy and biomarker analysis of nivolumab plus gemcitabine and cisplatin in patients with unresectable or metastatic biliary tract cancers: results from a phase II study

Publication history

  • Accepted April 23, 2020
  • First published June 2, 2020.
Online issue publication 
June 02, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.